Johnson & Johnson raises FY2026 operational sales growth outlook to 6.7% — 7.1%
Johnson & Johnson raised 2026 operational sales growth guidance to 6.7%-7.1%, implying USD 100.7 billion at the midpoint. Reported sales growth forecast lifted to 7.2%-7.6%, implying USD 101.2 billion at the midpoint, based on a USD 1.15 average euro rate. Adjusted operational EPS outlook set at USD 10.95-11.05; report